Our Areas of Focus
Serum BCMA Testing & Services
Janus Kinase Inhibitors
Patent issued for combination of JAKi’s with immunomodulatory agents for anti-cancer applications.
Gamma Secretase Inhibitors
Patent pending for use-case of GSI as a treatment potentiator for BCMA-targeted therapies to treat multiple myeloma.
A transformative innovator in enabling data-driven treatment decisions to improve outcomes for cancer patients and reduce the cost of care.